Self-Administered Parenteral Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theSelf-Administered Parenteral Market?
The rise in chronic illnesses is anticipated to fuel the expansion of the self-administered parenteral market. Chronic illnesses are persistent health problems that typically gradual progression and frequently necessitate ongoing management and therapy. Self-administered parenteral products, used for chronic disease management, enable patients to handle their treatment autonomously, leading to significantly greater adherence than oral medication. For instance, the National Institutes of Health, a US-based government agency, reported in January 2023 that the number of individuals 50 and above with at least one chronic disease is predicted to surge by 99.5% from 71.522 million in 2020 up to 142.66 million by 2050. Consequently, the escalating prevalence of chronic diseases acts as a growth driver for the self-administered parenteral market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp
#What is the Projected CAGR for the Self-Administered Parenteral Market Size from 2025 to 2034?
The market size for self-administered parenteral therapies has seen significant expansion in the last few years. Anticipated growth is from $24.57 billion in 2024 to $26.04 billion in 2025, representing a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this historical growth include the increasing prevalence of chronic illnesses, an aging demographic, government-led initiatives, patient awareness and support frameworks, and a surge in bone disorder cases.
Anticipations predict a consistent increase in the size of the self-administered parenteral market in the upcoming years. By 2029, it’s projected to reach $31.18 billion, fueled by a compound annual growth rate (CAGR) of 4.6%. This progression over the forecast period is tied to growing patient inclination towards home healthcare, advancements in telemedicine and remote patient monitoring, heightened patient education, and burgeoning personalized medicine. Key trends forecasted within this period involve the incorporation of digital health solutions, personalized drug delivery systems, the rise of targeted therapies, and biologics advancements.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13927
Which Upcoming Market Trends and Innovations Are Set to Influence theSelf-Administered Parenteral Market’s Path Forward?
Leading firms in the self-administered parenteral market are aiming to develop revolutionary products such as the UDENYCA autoinjector. This is to offer more options and control, and ultimately make treatments more accessible for patients. Essentially, an autoinjector is a medical tool designed to deliver a one-time dose of a specific drug. Its design is easy to understand and it can be activated instantly and reliably by pressing it against the skin. For example, in May 2023, US biotech firm Coherus BioSciences Inc. released the UDENYCA autoinjector, a self-administered parenteral medication in the US. This is a single-dose, prefilled autoinjector meant to offer patients an alternative way to administer pegfilgrastim. It is designed in such a way that it can be quickly and reliably activated by pressing it against the skin, ensuring the immediate delivery of a full dose of pegfilgrastim. Besides, this autoinjector offers several features that make it user-friendly and encourage successful delivery. It offers rapid dosing, an intuitive design, dual-coverage, it can be used at home or in the office, and it minimizes the risk of febrile neutropenia.
Who Are the Dominant Market Players Pushing the Boundaries of theSelf-Administered Parenteral Market?
Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report
What Are the Core Segments of the Self-Administered Parenteral Market, and How Do They Contribute to Growth?
The self-administered parenteral market covered in this report is segmented –
1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications
Subsegments:
1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes
2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors
3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors
4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13927&type=smp
What Regions Are Dominating the Self-Administered Parenteral Market Growth?
North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Self-Administered Parenteral Market 2025, By The Business Research Company:
Residential Substance Abuse And Mental Health Facilities Global Market Report 2024
Payer Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/payer-services-global-market-report
Platform as a service (PaaS) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/platform-as-a-service-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
